Filing Details
- Accession Number:
- 0001179110-18-006500
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-09 19:21:04
- Reporting Period:
- 2018-05-07
- Accepted Time:
- 2018-05-09 19:21:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1199632 | J William Bolt | C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923 | Svp, Qa And Regulatory Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par | Acquisiton | 2018-05-07 | 1,666 | $99.62 | 66,414 | No | 4 | M | Direct | |
| Common Stock, $.01 Par | Acquisiton | 2018-05-07 | 4,000 | $66.25 | 70,414 | No | 4 | M | Direct | |
| Common Stock, $.01 Par | Acquisiton | 2018-05-07 | 5,000 | $21.55 | 75,414 | No | 4 | M | Direct | |
| Common Stock, $.01 Par | Acquisiton | 2018-05-07 | 5,000 | $23.15 | 80,414 | No | 4 | M | Direct | |
| Common Stock, $.01 Par | Disposition | 2018-05-07 | 1,545 | $345.21 | 78,869 | No | 4 | S | Direct | |
| Common Stock, $.01 Par | Disposition | 2018-05-07 | 2,655 | $346.20 | 76,214 | No | 4 | S | Direct | |
| Common Stock, $.01 Par | Disposition | 2018-05-07 | 5,408 | $347.02 | 70,806 | No | 4 | S | Direct | |
| Common Stock, $.01 Par | Disposition | 2018-05-07 | 2,713 | $347.98 | 68,093 | No | 4 | S | Direct | |
| Common Stock, $.01 Par | Disposition | 2018-05-07 | 7,901 | $349.06 | 60,192 | No | 4 | S | Direct | |
| Common Stock, $.01 Par | Disposition | 2018-05-07 | 1,000 | $350.01 | 59,192 | No | 4 | S | Direct | |
| Common Stock, $.01 Par | Disposition | 2018-05-07 | 1,368 | $350.94 | 57,824 | No | 4 | S | Direct | |
| Common Stock, $.01 Par | Disposition | 2018-05-07 | 200 | $352.16 | 57,624 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-05-07 | 5,000 | $0.00 | 5,000 | $23.15 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-05-07 | 5,000 | $0.00 | 5,000 | $21.55 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-05-07 | 4,000 | $0.00 | 4,000 | $66.25 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-05-07 | 1,666 | $0.00 | 1,666 | $99.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-05-14 | 2023-05-14 | No | 4 | M | Direct |
| 0 | 2015-05-14 | 2024-05-14 | No | 4 | M | Direct |
| 2,000 | 2016-05-13 | 2025-05-13 | No | 4 | M | Direct |
| 3,334 | 2017-05-24 | 2026-05-24 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $134.51 | 2018-05-15 | 2027-05-15 | 0 | 3,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2027-05-15 | 0 | 3,000 | Direct |
Footnotes
- These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of this option to buy the number of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- Exercise of stock options pursuant to reporting owners 10b5-1 plan.
- Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $344.5600 and $345.4900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $345.9500 and $346.5500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $346.5600 and $347.5500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $347.5600 and $348.3800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $348.5600 and $349.5000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $349.6600 and $350.3900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $350.7300 and $351.5000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $351.9700 and $352.3500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Billionaire Hedge Funds
